Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINA6 | P08185 | 1/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.70 |
| ▸ | SHBG | P04278 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.62 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | AR | P10275 | 4/20 | 0.62 |
| ▸ | PGR | P06401 | 4/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.62 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.62 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.62 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.62 |
| ▸ | HRH2 | P25021 | 1/20 | 0.62 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.62 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.62 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9066088 | 1.00 | SERPINA6 (0.72) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL9066081 | 1.00 | SERPINA6 (0.72) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL8645665 | 0.89 | CYP19A1 (0.63) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL8641143 | 0.89 | CYP19A1 (0.80) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL5708096 | 0.89 | AR (0.70) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL8645662 | 0.89 | CYP19A1 (0.63) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL8641139 | 0.89 | CYP19A1 (0.80) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL9549867 | 0.89 | AR (0.70) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL5708095 | 0.89 | AR (0.70) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 | |
| SCHEMBL10273745 | 0.87 | SERPINA6 (0.55) | SERPINA6CYP19A1SHBGCYP3A4NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130252930-A1 | CYP11B, CYP17, AND/OR CYP21 INHIBITORS | BIOMARIN PHARMACEUTICAL INC. (CA) | 2013-09-26 | — | — | US | disclosed |
| WO-2012083112-A2 | CYP11B, CYP17, AND/OR CYP21 INHIBITORS | BIOMARIN PHARMACEUTICAL INC. (US) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130252930-A1 | CYP11B, CYP17, AND/OR CYP21 INHIBITORS | CYP4A11, HSD17B11, CYP21A2 | SERPINA6 360/4885CYP19A1 10/4885SHBG 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.